Despite the excellent performance of sensitive cardiac troponin assays in the early diagnosis of acute myocardial infarction, they should be used only in conjunction with a detailed clinical assessment. For example, differentiating acute myocardial infarction from other medical conditions associated with elevations in cardiac troponin levels, including myocarditis and heart failure, will continue to require a full clinical evaluation.